These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10546132)

  • 41. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and management of ventricular tachycardia.
    Naik N; Talwar KK
    J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decision to implant a cardioverter defibrillator after myocardial infarction: the role of ejection fraction v. other risk factor markers.
    Bailey JJ; Hodges M; Church TR
    Med Decis Making; 2007; 27(2):151-60. PubMed ID: 17409365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tachycardia-induced cardiomyopathy].
    Komamura K
    Nihon Rinsho; 2007 May; 65 Suppl 5():439-45. PubMed ID: 17571416
    [No Abstract]   [Full Text] [Related]  

  • 46. [Arrhythmia as risk factor].
    Internist (Berl); 1997 Feb; 38(2 Suppl Risikofakt):1-8. PubMed ID: 9330651
    [No Abstract]   [Full Text] [Related]  

  • 47. Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease.
    Yeo KK; Cruz L; Hong R
    Hawaii Med J; 2006 Mar; 65(3):86-7. PubMed ID: 16724450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].
    Jordaens L; Tavernier R
    J Med Liban; 1999; 47(3):181-9. PubMed ID: 10550944
    [No Abstract]   [Full Text] [Related]  

  • 51. Life-threatening arrhythmias and therapy.
    Myerburg RJ
    Resuscitation; 2000 Aug; 45(3):S1-2. PubMed ID: 10959026
    [No Abstract]   [Full Text] [Related]  

  • 52. The SWORD of Damocles.
    Sanderson J
    Lancet; 1996 Jul; 348(9019):2-3. PubMed ID: 8691925
    [No Abstract]   [Full Text] [Related]  

  • 53. [Compensating mechanism in cardiac insufficiency and therapeutic-preventive principles].
    Urbaszek W; Köhler H
    Z Gesamte Inn Med; 1973 May; 28(9):257-62. PubMed ID: 4147282
    [No Abstract]   [Full Text] [Related]  

  • 54. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy.
    Klein GJ; Krahn AD; Skanes AC; Yee R; Gula LJ
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S28-34. PubMed ID: 16138882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical therapy for arrhythmias and EBM].
    Otsuka T; Yamashita T
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):234-9. PubMed ID: 16536072
    [No Abstract]   [Full Text] [Related]  

  • 58. [Secondary prevention following myocardial infarction--results of long-term studies].
    Berndt H
    Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
    Schwartz PJ
    Cardiologia; 1996 Aug; 41(8):739-45. PubMed ID: 8925528
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.